AP425A - "Benzofuran derivatives and their use in the treatment of migraine". - Google Patents
"Benzofuran derivatives and their use in the treatment of migraine". Download PDFInfo
- Publication number
- AP425A AP425A APAP/P/1993/000581A AP9300581A AP425A AP 425 A AP425 A AP 425A AP 9300581 A AP9300581 A AP 9300581A AP 425 A AP425 A AP 425A
- Authority
- AP
- ARIPO
- Prior art keywords
- formula
- compound
- ethyl
- benzofuranyl
- acetyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929221761A GB9221761D0 (en) | 1992-10-16 | 1992-10-16 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9300581A0 AP9300581A0 (en) | 1993-10-31 |
| AP425A true AP425A (en) | 1995-11-08 |
Family
ID=10723562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1993/000581A AP425A (en) | 1992-10-16 | 1993-10-15 | "Benzofuran derivatives and their use in the treatment of migraine". |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5494910A (es) |
| EP (1) | EP0664804A1 (es) |
| JP (1) | JPH06211842A (es) |
| KR (1) | KR940009179A (es) |
| CN (1) | CN1092420A (es) |
| AP (1) | AP425A (es) |
| AU (1) | AU5333794A (es) |
| CA (1) | CA2146569A1 (es) |
| CZ (1) | CZ96895A3 (es) |
| EC (1) | ECSP941050A (es) |
| FI (1) | FI951798A (es) |
| GB (1) | GB9221761D0 (es) |
| HU (1) | HUT72752A (es) |
| IL (1) | IL107302A0 (es) |
| IS (1) | IS4081A (es) |
| MX (1) | MX9306394A (es) |
| NO (1) | NO951433D0 (es) |
| PE (1) | PE51294A1 (es) |
| PL (1) | PL308357A1 (es) |
| RU (1) | RU95110110A (es) |
| SI (1) | SI9300542A (es) |
| TW (1) | TW262473B (es) |
| WO (1) | WO1994008993A1 (es) |
| ZA (1) | ZA937633B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407447D0 (en) * | 1994-04-14 | 1994-06-08 | Glaxo Group Ltd | Chemical compounds |
| WO1995032196A1 (en) * | 1994-05-19 | 1995-11-30 | Merck Sharp & Dohme Limited | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
| GB9610979D0 (en) * | 1996-05-24 | 1996-07-31 | Merck Sharp & Dohme | Therapeutic agents |
| JP2001501946A (ja) * | 1996-10-08 | 2001-02-13 | イーライ・リリー・アンド・カンパニー | 新規セロトニン５―ｈｔ▲下１ｆ▼アゴニスト |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US20030198669A1 (en) * | 2001-07-05 | 2003-10-23 | R.T. Alamo Ventures I, Llc | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
| US20030017175A1 (en) * | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
| US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| US9399053B2 (en) | 2011-07-22 | 2016-07-26 | The University Of Chicago | Treatments for migraine and related disorders |
| KR101443041B1 (ko) * | 2013-05-06 | 2014-09-23 | (주)하이레벤 | 태양광 발전설비의 효율향상설비 |
| WO2023018864A1 (en) | 2021-08-12 | 2023-02-16 | Psilosterics, Llc | Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670105A1 (de) * | 1966-07-08 | 1970-12-10 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
-
1992
- 1992-10-16 GB GB929221761A patent/GB9221761D0/en active Pending
-
1993
- 1993-10-11 IS IS4081A patent/IS4081A/is unknown
- 1993-10-14 EP EP93923463A patent/EP0664804A1/en not_active Withdrawn
- 1993-10-14 ZA ZA937633A patent/ZA937633B/xx unknown
- 1993-10-14 RU RU95110110/04A patent/RU95110110A/ru unknown
- 1993-10-14 WO PCT/EP1993/002833 patent/WO1994008993A1/en not_active Application Discontinuation
- 1993-10-14 US US08/406,981 patent/US5494910A/en not_active Expired - Fee Related
- 1993-10-14 PL PL93308357A patent/PL308357A1/xx unknown
- 1993-10-14 AU AU53337/94A patent/AU5333794A/en not_active Abandoned
- 1993-10-14 KR KR1019930021263A patent/KR940009179A/ko not_active Application Discontinuation
- 1993-10-14 CA CA002146569A patent/CA2146569A1/en not_active Abandoned
- 1993-10-14 HU HU9501073A patent/HUT72752A/hu unknown
- 1993-10-14 CZ CZ95968A patent/CZ96895A3/cs unknown
- 1993-10-14 MX MX9306394A patent/MX9306394A/es unknown
- 1993-10-15 SI SI9300542A patent/SI9300542A/sl unknown
- 1993-10-15 JP JP5258631A patent/JPH06211842A/ja active Pending
- 1993-10-15 CN CN93115016A patent/CN1092420A/zh active Pending
- 1993-10-15 IL IL107302A patent/IL107302A0/xx unknown
- 1993-10-15 AP APAP/P/1993/000581A patent/AP425A/en active
- 1993-11-04 TW TW082108174A patent/TW262473B/zh active
-
1994
- 1994-03-02 EC EC1994001050A patent/ECSP941050A/es unknown
- 1994-04-13 PE PE1994240029A patent/PE51294A1/es not_active Application Discontinuation
-
1995
- 1995-04-12 NO NO951433A patent/NO951433D0/no unknown
- 1995-04-13 FI FI951798A patent/FI951798A/fi unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670105A1 (de) * | 1966-07-08 | 1970-12-10 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9221761D0 (en) | 1992-12-02 |
| NO951433L (no) | 1995-04-12 |
| IL107302A0 (en) | 1994-01-25 |
| HUT72752A (en) | 1996-05-28 |
| AU5333794A (en) | 1994-05-09 |
| WO1994008993A1 (en) | 1994-04-28 |
| CA2146569A1 (en) | 1994-04-28 |
| US5494910A (en) | 1996-02-27 |
| PE51294A1 (es) | 1995-01-06 |
| FI951798A0 (fi) | 1995-04-13 |
| HU9501073D0 (en) | 1995-06-28 |
| ECSP941050A (es) | 1994-11-16 |
| JPH06211842A (ja) | 1994-08-02 |
| CZ96895A3 (en) | 1995-12-13 |
| TW262473B (es) | 1995-11-11 |
| MX9306394A (es) | 1994-05-31 |
| CN1092420A (zh) | 1994-09-21 |
| PL308357A1 (en) | 1995-07-24 |
| KR940009179A (ko) | 1994-05-20 |
| FI951798A (fi) | 1995-04-13 |
| EP0664804A1 (en) | 1995-08-02 |
| SI9300542A (en) | 1994-06-30 |
| IS4081A (is) | 1994-04-17 |
| ZA937633B (en) | 1994-08-01 |
| AP9300581A0 (en) | 1993-10-31 |
| NO951433D0 (no) | 1995-04-12 |
| RU95110110A (ru) | 1996-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1310968C (en) | Indole derivatives | |
| US5036078A (en) | Piperidinyl indoles for migraine treatment | |
| AU625192B2 (en) | Piperazine compounds | |
| AU704495B2 (en) | Benzofurans | |
| AP425A (en) | "Benzofuran derivatives and their use in the treatment of migraine". | |
| JP3834098B2 (ja) | ベンゾニトリル類およびベンゾフルオリド類 | |
| WO1993014077A1 (en) | Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation | |
| IE55358B1 (en) | Indoles | |
| JPS63146874A (ja) | インドール誘導体 | |
| JP2002533391A (ja) | 偏頭痛の治療のためのインドールおよびインドリジジン誘導体 | |
| GB2299581A (en) | 3-(Tetrahydropyridin-1-yl-methyl)pyrrolo[2,3-b]pyridine derivatives as ligands for dopamine receptor subtypes | |
| JP2941333B2 (ja) | インドール誘導体 | |
| JP4137956B2 (ja) | 複素環化合物 | |
| US5770611A (en) | Indole derivatives as 5HT1 -like agonists | |
| JP2941702B2 (ja) | ５‐ｈｔ３レセプターにおいて５‐ｈｔの作用に拮抗するラクタム誘導体を含む医薬組成物 | |
| HUT53607A (en) | Process for production of derivatives of cyclohexan-acetamid | |
| JPH09216879A (ja) | （１ｈ−インドール−４−イル）−ピペリジンまたはテトラヒドロピリジンのエチルアミンおよびエチルカルボキサミド | |
| EP0345956B1 (en) | Tricyclic ketones | |
| WO1995021166A1 (en) | Triazole derivatives | |
| CA2456233A1 (en) | Paroxetine isethionate salt, process of preparation and use in the treatment of depression |